Galectin Therapeutics Inc. (GALT) Surges on Promising Belapectin Trial Data and Strong Financials
Galectin Therapeutics Inc.
Galectin Therapeutics Inc (GALT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 144,528 | $304,954 | 0% | |
| 2. | Citadel Investment Group Ken Griffin | 103,297 | $217,957 | 0% | |
| 3. | 69,100 | $145,801 | -42% | 0% | |
| 4. | 54,800 | $115,628 | -50% | 0% | |
| 5. | Horizon Asset Management Murray Stahl | 51,484 | $108,631 | -5% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.93 | 1,000 | $2,925.00 | 64,682 | 2025-07-21 | Filing | |
| $2.90 | 5,000 | $14,495.00 | 49,769 | 2025-07-17 | Filing | |
| $1.16 | 6,500 | $7,540.00 | 15,206 | 2024-12-30 | Filing | |
| $0.82 | 10,000 | $8,164.00 | 42,083 | 2024-12-24 | Filing | |
| $0.82 | 13,469 | $11,044.58 | 63,682 | 2024-12-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.06 | 3,677 | $11,251.62 | 5,922,207 | 2024-04-23 | Filing | |
| $3.06 | 21,323 | $65,248.38 | 5,925,884 | 2024-04-22 | Filing | |
| $6.44 | 8,706 | $56,053.58 | 7,614 | 2025-09-12 | Filing | |
| $6.36 | 14,000 | $89,048.40 | 832,592 | 2025-09-12 | Filing | |
| $0.88 | 13,654 | $12,044.19 | 26,346 | 2024-12-23 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,000 | $42,350 | 0% | |
| 2. | 2,980 | $14,155 | 0% | |
| 3. | 167 | $708 | 0% | |
| 4. | 330 | $1 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
15 Best Biotech Penny Stocks to Invest in Right Now
Jared Holz, the healthcare strategist for Mizuho, spoke on CNBC's "Closing Bell Overtime" in July on whether the biotech industry is ready for a breakthrough.
Is Galectin Therapeutics Inc. (GALT) A Good Stock To Buy?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Hedge Funds Are Souring On Galectin Therapeutics Inc. (GALT)
In this article we will check out the progression of hedge fund sentiment towards Galectin Therapeutics Inc. (NASDAQ:GALT) and determine whether it is a good investment right now.
Is Galectin Therapeutics Inc. (GALT) Going to Burn These Hedge Funds?
We at Insider Monkey have gone over 752 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of September...
Market Movers Today: Acxiom Corporation (ACXM), GameStop Corp. (GME), Galectin Therapeutics Inc. (GALT), Verint Systems Inc. (VRNT), and More
(Reuters) - Shares of Acxiom Corp (ACXM.O) plunged as much as 34 percent on Thursday, after Facebook Inc (FB.O) said it would end its partnerships with several large data brokers who help advertisers ...
Why Traders Are Talking About Origin Agritech, Galectin, Avis, Hertz, and More
In this article, we'll analyze why Origin Agritech Ltd. (NASDAQ:SEED), Galectin Therapeutics Inc (NASDAQ:GALT), Avis Budget Group Inc.
NASH Hype Has These 2 Stocks Soaring, Plus the Latest On MGT Capital, PTC Therapeutics, and Cloud Peak Energy
There is little fear on the Street today, as all three major indexes are moderately higher.
Is Supernus Pharmaceuticals Inc (SUPN) Going to Burn These Hedge Funds?
To most shareholders, hedge funds are perceived as slow, outdated investment vehicles of yesteryear.